Navigation Links
UCLA-industry partnership to develop, commercialize new nanotechnology
Date:12/17/2007

The California NanoSystems Institute (CNSI) at UCLA and NanoPacific Holdings Inc. have announced a partnership to commercialize a mechanized, nanoparticle-based technology that could lead to prolonged lives of enhanced quality for millions of cancer sufferers.

Under the terms of the partnership, NanoPacific will receive exclusive license to key intellectual property owned by UCLA and developed at the CNSI's Nano Machine Center. The newly formed company will provide funding for further research at the center to broaden the scope of the technology for a diverse range of applications.

"This partnership is a prime example of how the CNSI will fulfill its mission," said UCLA Chancellor Gene Block. "Working with industry to bring new developments in technology and biotechnology into the marketplace for the benefit of the people of California is exactly why the CNSI was established."

The first application under the new partnership will involve the use of the technology for the targeted delivery of Food and Drug Administration-approved chemotherapeutic agents to cancer cells. Because of their unique properties, the mechanized nanoparticles can be preprogrammed to seek out cancer cells specifically while avoiding the body's other rapidly growing cells. In addition, the robot-like nanoparticles allow for the triggered release of cancer drugs that are currently difficult to administer intravenously because of their low solubilities in the blood stream.

The delivery mechanism consists of porous nanoparticles that are capable of storing and selectively releasing small drug molecules via nanoscale gates that can be opened and closed at will on the particles' surfaces. In this way, drugs can be loaded and unloaded in a selective manner in different environments. By equipping the nanoparticle surfaces with specific tags to preferentially target cancer cells, diseased cells can be destroyed selectively without affecting healthy on
'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
2. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
3. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
4. B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership
5. NASN Joins Partnership to Fight Chronic Disease
6. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
7. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
8. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
9. Partnership to Fight Chronic Disease Announces Ideas for Change in Health Care
10. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
11. Anthem Blue Cross and Blue Shield Partnership Plan Wins Nevada Immunization Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ewswire/ -- Ingenious Med (IM) welcomes new CEO, S...in inpatient practice,management solutions, with ...,software, revenue management, medical services, ...e-year CEO, Dr. Steven Liu, is confident Williford...nt in all sectors, as he steps into,the role. Liu...
(Date:12/2/2008)... who took it in first 3 months more likely to have...ealthDay News) -- Infants whose mothers take folic...increased risk for respiratory illness, according ...o reduce the risk of birth defects, and many count... researchers examined data on more than 32,000 chi...
(Date:12/2/2008)...earchers at The University of Nottingham has ident...er. , The research, published in the journal Pr...A and funded by a 72,000 grant from the British Lu...r gene, LIMD1, is responsible for protecting the b...r possible new treatments and early screening tech...
(Date:12/2/2008)...cs, Inc., a privately held biopharmaceutical compa...s evaluating its lead investigational product cand...1, a novel, proprietary fixed-dose combination pro...ated a statistically significant reduction in the ...(NSAID)-induced upper gastrointestinal (gastric an...
Breaking Medicine News(10 mins):Health News:Ingenious Med Hires New CEO to Maintain and Further Expand Company Development 2Health News:Folate in Early Pregnancy May Boost Wheezing in Baby 2Health News:Gene which protects against lung cancer identified 2Health News:Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints 2
...ystatin C test appears to be a good alternative fo...ular disease, that the creatinine test might miss/...ancisco VA Medical Center, has shown the inefficac... is incapable of picking up chronic health risks a...
...rchers from the US have shown that yellow plant pi...oping// age-related macular degeneration (AMD). Th...ity of Wisconsin, which has been published in the ...carrots might not actually help a person in the da...
...perimental RNA-based drug acts by using genetic ma..., and another type, called silencing RNA// , to st...s alive, thereby destroying prostate cancer cells ... The drug, developed at Duke University Medical C...
...aining popularity of unpasteurized milk has raised... While people consume unpasteurized milk for a var...g that unpasteurized milk are healthier and tastie... who consume it do fall sick. There been have ins...
Other Medicine News:Health News:Cystatin C Test- A Reliable Test to Detect Chronic Health Risks 2Health News:Cystatin C Test- A Reliable Test to Detect Chronic Health Risks 3Health News:Yellow Fruits And Vegetables Help In Fight Against Loss Of Eyesight 2
(Date:12/1/2008)...irl with Hypophosphatasia Treated With ENB-0040 at...nnipeg , , MONTREAL, Dec. 1 ...ny focused on developing novel therapeutics for se...st infant patient in its clinical program for hypo...zyme Replacement Therapy (ERT) with ENB-0040 for t...
(Date:12/1/2008)...TH MEETING, Pa., Dec. 1 ...nced that dosing of subjects has begun in study MS...se Phase 1b study of trodusquemine (MSI-1436) in o...a novel therapeutic for the treatment of type 2 di...herally to regulate insulin and leptin pathways th...
(Date:12/1/2008)...A, Dec. 1 GeoVax Labs, I...biotechnology company developing,human vaccines f...y Virus) and,other infectious agents, announced t...e Trials will take place in twelve sites across No... in collaboration with The National Institutes of,...
(Date:11/30/2008)...O, Dec. 1 Abnormalities...ted in children with autism spectrum disorder by u...study presented today at the annual meeting of the... , "Using MEG, we can record the tiny magneti...," said Timothy Roberts, Ph.D., vice chair of rese...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Disability payments may spur drug abuse 14 1Disability payments may spur drug abuse 14 2MRI finds breast cancer before it becomes dangerous 9 1MRI finds breast cancer before it becomes dangerous 9 2MRI finds breast cancer before it becomes dangerous 9 3Survival differences by race most apparent in advanced stages of breast cancer 4 1Survival differences by race most apparent in advanced stages of breast cancer 4 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long Term Results 96 1New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long Term Results 96 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long Term Results 96 3
...ginal Vibratome Semi-Automatic Tissue Sectioning S...d tissue sectioning system. Researchers from aroun...sic for their fresh and fresh fixed tissue section...Automatic Tissue Sectioning Systems, the biologica...
...ratome 1000 Plus Sectioning System provides a vers...or plant tissues. The 1000 employs a vibrating bl...zing or embedding. The creation of artifacts, the...me activities, and other deleterious effects inher...
The Vibratome comes standard with a square vice mounting device. These specimen blocks are utilized for mounting specimens and placing in the Vibratome holding vice. The blocks are annodized black
This is a perfect tool for retrieving free floating sections from the Vibratome bath.
Medicine Products: